| Size | Price | |
|---|---|---|
| 100mg | ||
| 250mg | ||
| 500mg |
| ln Vitro |
In CYP450 induction experiments, CCR4-351 (compound 38) hydrochloride has no activity [1]. The migration of mouse iTreg cells is inhibited by CCR4-351 hydrochloride at an IC50 of 39 nM, whereas the IC50 of human iTreg cells is 33 nM [1].
|
|---|---|
| ln Vivo |
CCR4-351 (Compound 38; 50 mg/kg; oral; daily; for 40 days) hydrochloride effectively decreases tumor development [1]. CCR4-351 (0.5 mg/kg; IV) hydrochloride has low clearance (CL=10.2 mL/min/kg), medium volume of distribution (Vss=5.2 L/kg), T1/2 of 6.9 h and high Bioavailability (%F = 29) Oral delivery to mice [1]. CCR4-351 hydrochloride has a low clearance (CL=7.3 mL/min/kg), a half-life of 12.7 hours, and a bioavailability of 44% in dogs. CCR4-351 hydrochloride has low clearance (CL=3.7 mL/min/kg), extended terminal half-life (10.7 hours), and good bioavailability (%F = 41) in cynomolgus monkeys [1].
|
| Animal Protocol |
Animal/Disease Models: 6 to 8 weeks old female C57BL/6 mice with Pan02-OVA tumors [1]
Doses: 50 mg/kg Route of Administration: Oral; daily; continued for 40 days Experimental Results: Significant reduction in tumor growth . Animal/Disease Models: Rat and Mouse[1] Doses: 0.5 mg/kg IV; 2 mg/kg PO Route of Administration: IV or PO Experimental Results: Rats had moderate clearance after oral administration (CL=47.6 mL/min /kg) and the bioavailability is 49%. Oral administration to mice demonstrated low clearance (CL=10.2 mL/min/kg), medium volume of distribution (Vss=5.2 L/kg), T1/2 of 6.9 hrs (hrs (hours)), and good bioavailability (%F = 29) . |
| References |
[1]. Omar Robles, et al. Novel Piperidinyl-Azetidines as Potent and Selective CCR4 Antagonists Elicit Antitumor Response as Single Agent and in Combination with Checkpoint Inhibitors. J Med Chem. 2020 Jul 15.
|
| Molecular Formula |
C24H27CL2N7O.XHCL
|
|---|---|
| Molecular Weight |
536.88
|
| CAS # |
2174938-71-5
|
| Related CAS # |
CCR4-351;2174938-70-4
|
| SMILES |
[C@@H](C1C=CC(Cl)=CC=1Cl)(N1N=C(C#N)C2=NC=C(N3CC([C@H]4CCCN(CCO)C4)C3)N=C12)C.Cl
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO : ~170 mg/mL
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 4.25 mg/mL (Infinity mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 42.5 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 4.25 mg/mL (Infinity mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 42.5 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly. (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 1.8626 mL | 9.3131 mL | 18.6261 mL | |
| 5 mM | 0.3725 mL | 1.8626 mL | 3.7252 mL | |
| 10 mM | 0.1863 mL | 0.9313 mL | 1.8626 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
